Consistently, p53 and p53R2 may have a tumor-promoting function in cancers with cytoplasmic p21 (and Akt overexpressing cancers), and support the development of chemoresistance against anticancer therapeutics leading to poor prognosis. Here, TP53 is linked to cancer.